Defibrillators companies

  • Report ID: 4284
  • Published Date: Aug 14, 2025
  • Report Format: PDF, PPT

Key Defibrillators Market Players:

    The commercial dynamics in the defibrillators market are primarily shaped by ongoing updates in regulatory compliance, progress in product innovation, and empowerment of brand's presence. This can be exemplified by ZOLL's acquisition of compliance with the Medical Device Regulation 2017/745 from the European Union (EU) for its AED Plus and AED 3 defibrillators in October 2024. This positioned the company at the forefront of competency within Europe by reinforcing trust among healthcare providers and buyers with enhanced safety and efficacy. Moreover, as the urge to meet evolving regulatory standards amplifies among global leaders, the development of advanced, user-friendly technologies is accelerated.

    • Medtronic (Ireland/U.S.)
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Boston Scientific (U.S.)
    • Abbott Laboratories (U.S.)
    • Philips (Netherlands)
    • ZOLL Medical (U.S.)
    • Biotronik (Germany)
    • Schiller AG (Switzerland)
    • Stryker (U.S.)
    • Defibtech (U.S.)
    • Mindray (China)
    • CU Medical Systems (South Korea)
    • BPL Medical Technologies (India)
    • Metrax GmbH (Germany)
    • Bexen Cardio (Spain)
    • Instramed (Australia)
    • Mediana (South Korea)
    • Cardia (Malaysia)
    • Metsis Medikal (Turkey)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of the defibrillators market was over USD 10.8 billion.

The market size for the defibrillators market is projected to reach USD 23.1 billion by the end of 2035, expanding at a CAGR of 9% during the forecast period, i.e., between 2026-2035.

The major players in the market are Medtronic, Boston Scientific, Abbott Laboratories, Philips, ZOLL Medical, Biotronik, and others.

In terms of product type, the implantable cardioverter defibrillators (ICDs) segment is anticipated to garner the largest market share of 54.6% by 2035 and display lucrative growth opportunities during 2026-2035.

The market in North America is projected to hold the largest market share of 42.3% by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos